On Feb. 2, State Senator Monique Limón introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient.  This bill was sponsored in partnership between UC and the American Cancer Society Cancer Action Network (ACS CAN).

“The advances in cancer treatment that have come from being able to tailor approaches to a person’s individual condition are critical for winning the fight against cancer. This legislation will bring the hope and promise of precision medicine to people with a cancer diagnosis across the state on an equitable basis,” said Carrie L. Byington, M.D., executive vice president of University of California Health and an infectious disease expert. “California has the opportunity to be among the leaders in the nation with this legislation.”

Read the full story at fightcancer.org

About

View all post by